Paternal Exposure Pilot Study

  • Research type

    Research Study

  • Full title

    Paternal Exposure Pilot: Neurodevelopmental outcomes in children and adolescents born to men with epilepsy

  • IRAS ID

    331120

  • Contact name

    Matthew Bluett-Duncan

  • Contact email

    matthew.bluett-duncan@manchester.ac.uk

  • Sponsor organisation

    The University of Manchester

  • Clinicaltrials.gov Identifier

    N/A, N/A

  • Duration of Study in the UK

    0 years, 2 months, 28 days

  • Research summary

    The MHRA has recently introduced new guidance that restricts the prescribing of Sodium Valproate in men aged under 55 years. This is because of evidence from animal studies that there may be a risk of fertility issues in men taking valproate. There is also some evidence of risk to development in offspring of mice, but the data is at present too limited to understand the impact on the development of human children, either in sodium Valproate or other anti-seizure medications. It is important that we investigate so that we can better understand the neurodevelopmental outcomes of children born to men with epilepsy and whether they differ by the anti-seizure medications received. This study is a pilot study and will be completed to help us prepare for a larger study.

    We will first investigate how many males with epilepsy that are attending one of the participating hospitals during the study period have biological children aged 6-15 years. We will then investigate how many of these patients and their children would be willing to participate in a study where their child would have a review of their development and will test how we would complete a full assessment in a small group of participants.

    Men with epilepsy who had received their diagnosis before their children were conceived, with a child aged 6-15 years 11 months and 30 days, and who are receiving their health care at either the Walton Centre or Salford Royal Hospital will be eligible for participation in this pilot. Participants taking part in Stage 1 will complete a short online questionnaire (5 mins), and those participating in Stage 2 will complete a developmental assessment with their child, and the child's birth mother (1-2 hours). Assessments will be conducted at home, in hospital, or at school, depending on participant preference.

  • REC name

    West Midlands - Black Country Research Ethics Committee

  • REC reference

    23/WM/0238

  • Date of REC Opinion

    11 Dec 2023

  • REC opinion

    Further Information Favourable Opinion